Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IMIPENEM: 1,879 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
1,879
Total FAERS Reports
604 (32.1%)
Deaths Reported
826
Hospitalizations
1,879
As Primary/Secondary Suspect
205
Life-Threatening
27
Disabilities

First Report: 18991231 · Latest Report: 20250527

What Are the Most Common IMIPENEM Side Effects?

#1 Most Reported
Drug ineffective
351 reports (18.7%)
#2 Most Reported
Off label use
202 reports (10.8%)
#3 Most Reported
Condition aggravated
138 reports (7.3%)

All IMIPENEM Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Drug ineffective 351 18.7% 156 176
Off label use 202 10.8% 74 110
Condition aggravated 138 7.3% 38 55
Vomiting 137 7.3% 38 60
Drug resistance 117 6.2% 27 44
Nausea 111 5.9% 12 47
Dyspnoea 97 5.2% 58 68
Diarrhoea 90 4.8% 50 43
Pyrexia 90 4.8% 30 61
Product use in unapproved indication 85 4.5% 12 22
Thrombocytopenia 84 4.5% 9 33
Treatment failure 82 4.4% 48 38
Multiple organ dysfunction syndrome 80 4.3% 63 35
Electrocardiogram qt prolonged 76 4.0% 14 38
Acute kidney injury 71 3.8% 23 42
Death 63 3.4% 63 33
Renal failure 60 3.2% 39 23
Septic shock 60 3.2% 32 40
Eosinophilia 59 3.1% 1 17
Rash maculo-papular 58 3.1% 2 16

Who Reports IMIPENEM Side Effects? Age & Gender Data

Gender: 40.5% female, 59.5% male. Average age: 50.1 years. Most reports from: US. View detailed demographics →

Is IMIPENEM Getting Safer? Reports by Year

YearReportsDeathsHosp.
2001 3 2 1
2002 5 0 2
2008 1 0 0
2010 3 0 3
2011 3 0 1
2012 3 0 3
2013 3 1 1
2014 19 8 11
2015 29 6 17
2016 44 9 18
2017 96 45 48
2018 123 60 52
2019 84 31 55
2020 85 27 52
2021 103 11 41
2022 54 3 28
2023 23 0 6
2024 12 0 3
2025 9 0 2

View full timeline →

What Is IMIPENEM Used For?

IndicationReports
Tuberculosis 241
Product used for unknown indication 233
Mycobacterium abscessus infection 178
Antibiotic therapy 114
Pulmonary tuberculosis 92
Nocardiosis 85
Infection 64
Pneumonia 56
Klebsiella infection 37
Sepsis 37

IMIPENEM vs Alternatives: Which Is Safer?

IMIPENEM vs IMIPRAMINE IMIPENEM vs IMIQUIMOD IMIPENEM vs IMITREX IMIPENEM vs IMMUNE GLOBULIN NOS IMIPENEM vs IMPLANON IMIPENEM vs INAVOLISIB IMIPENEM vs INCIVEK IMIPENEM vs INCIVO IMIPENEM vs INCLISIRAN IMIPENEM vs INCOBOTULINUMTOXINA

Official FDA Label for IMIPENEM

Official prescribing information from the FDA-approved drug label.